메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Misi He (Chongqing University Cancer Hospital Chongqing China) Mingfang Guo (Chongqing University Cancer Hospital Chongqing China) Qi Zhou (Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital) Ying Tang (Chongqing University Cancer Hospital Chongqing China) Lin Zhong (Chongqing University Cancer Hospital Chongqing China) Qing Liu (Gansu Provincial Maternity and Child-Care Hospital/Gansu Provincial Central Hospital Lanzhou China) Xiaomei Fan (Department of Gynecological Oncology The Fourth Hospital of Hebei Medical University Shijiazhuang) Xiwa Zhao (Fourth Hospital of Hebei Medical University Hebei China) Xiang Zhang (Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou China) Gang Chen (Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China) Yuanming Shen (Zhejiang University Hangzhou China) Qin Xu (Clinical Oncology School of Fujian Medical University Fujian Cancer Hospital Fuzhou China) Xiao-jun Chen (Department of Gynecology Obstetrics and Gynecology Hospital Fudan University Shanghai China) Yuancheng Li (Cancer Hospital of Shantou University Medicine College Shantou China) Dongling Zou (Chongqing University Cancer Hospital Chongqing China)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.34 No.3
발행연도
2023.5
수록면
1 - 10 (10page)
DOI
10.3802/jgo.2023.34.e55

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Cer vical cancer is still present a major public health problem, especially indeveloping countries. In International Federation of Gynaecology and Obstetrics 2018,allowing assessment of retroperitoneal lymph nodes by imaging and/or pathological findingsand, if deemed metastatic, the case is designated as stage IIIC (with r and p notations). Patients with lymph node metastases have lower overall sur vival (OS), progression freesur vival (PFS), and sur vival after recurrence, especially those who have unresectablemacroscopical positive lymph nodes. Retrospective analysis suggests that there may be abenefit to debulking macroscopic nodes that would be other wise difficult to sterilize withstandard doses of radiation therapy. However, there are no prospective study reporting thatresecting macroscopic nodes before concurrent chemoradiation therapy (CCRT) wouldimprove PFS or OS of cer vical cancer and no guidelines for surgical resection of bulky lymphnodes. The CQGOG0103 study is a prospective, multicenter and randomized controlled trial(RCT) evaluating lymph node dissection on stage IIICr of cer vical cancer. Methods: Eligible patients are histologically confirmed cer vical squamous cell carcinoma,adenocarcinoma, adeno-squamous cell carcinoma. Stage IIICr (confirmed by computedtomography [CT]/magnetic resonance imaging/positron emission tomography/CT) andthe short diameter of image-positive lymph node ≥15 mm. 452 patients will be equally randomized to receive either CCRT (pelvic external-beam radiotherapy [EBRT]/extended-field EBRT + cisplatin [40 mg/m2] or carboplatin [the area under cur ve=2] ever y week for5 cycles + brachytherapy) or open/minimally invasive pelvic and para-aortic lymph nodedissection followed by CCRT. Randomization is stratified by status of para-aortic lymphnode. The primar y endpoint is PFS. Secondar y endpoints are OS and surgical complications. A total of 452 patients will be enrolled from multiple hospitals in China within 4 years andfollowed up for 5 years.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0